Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
11
×
boston blog main
san francisco top stories
boston top stories
national top stories
new york blog main
biotech
new york top stories
san diego blog main
san diego top stories
san francisco
gene therapy
indiana blog main
indiana top stories
raleigh-durham blog main
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
fda
hemophilia
national
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
clinical trials
sangamo therapeutics
spark therapeutics
venture capital
alexandria venture investments
What
therapy
11
×
drug
gene
approval
bio
fda
patients
roundup
aren’t
cutting
developers
disease
edge
healthcare
help
long
market
medicines
moves
race
science
therapeutics
treat
address
advanced
agency
aimmune
allergy
alnylam’s
approved
approves
awarded
becker
benefits
better
bff
billions
blueprint
building
cancer
Language
unset
Current search:
therapy
×
" san francisco blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed